{"name": "Diagnostic Hybrids",
 "permalink": "diagnostic-hybrids",
 "crunchbase_url": "http://www.crunchbase.com/company/diagnostic-hybrids",
 "homepage_url": "http://www.dhiusa.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1983,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "customer_service@dhiusa.com",
 "phone_number": "740-589-3300",
 "description": "",
 "created_at": "Wed Jan 13 10:53:21 UTC 2010",
 "updated_at": "Wed Jan 13 10:53:21 UTC 2010",
 "overview": "\u003Cp\u003EDiagnostic HYBRIDS, Inc. develops, manufactures, and markets cellular and molecular diagnostic kits for various applications in detecting a range of respiratory diseases, herpes infections, thyroid function, and other markers of diseases. The company offers D3 FastPoint L-DFA influenza A/influenza B virus identification kit, which allows for the identification of influenza A virus and influenza B virus from a patient\u0026#8217;s specimen in under 30 minutes. It also develops and commercializes genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry with a focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines. In addition, the company provides an assortment of products for specimen collection, specimen transport, multi-virus cell culture amplification, and sensitive and specific virus detection using monoclonal antibody kits and reagents. Further, it offers respiratory, herpes family, chlamydia, and enterovirus testing solutions; monolayer cell line products for use in diagnosing and detecting viruses that cause human illness; C. difficile toxin; flocked swabs and UTM; and media and supplements, including prepared media, salt solutions, antibiotic solutions, and trypsin solutions. Furthermore, the company provides products and services for non-diagnostic applications, including in vitro toxicology and metabolism products and services, such as primary hepatocytes and hepatocyte-based assays. It also supports educational programs for influenza A, influenza B, RSV, MPV, Adenovirus, and Parainfluenza 1, 2, and 3 through direct speaker programs and educational grants, as well as Internet-based education programs. The company was formerly known as Molecular Diagnostics, Inc. Diagnostic HYBRIDS, Inc. was founded in 1983 and is based in Athens, Ohio.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[122,
       77],
      "assets/images/resized/0007/3172/73172v1-max-150x150.jpg"],
     [[122,
       77],
      "assets/images/resized/0007/3172/73172v1-max-250x250.jpg"],
     [[122,
       77],
      "assets/images/resized/0007/3172/73172v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "David",
      "last_name": "R. Scholl",
      "permalink": "david-r-scholl",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0018/8269/188269v2-max-150x150.jpg"],
          [[166,
            250],
           "assets/images/resized/0018/8269/188269v2-max-250x250.jpg"],
          [[300,
            450],
           "assets/images/resized/0018/8269/188269v2-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President and COO",
    "person":
     {"first_name": "James",
      "last_name": "L. Brown",
      "permalink": "james-l-brown",
      "image": null}},
   {"is_past": true,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Mr.Kevin",
      "last_name": "Pollack",
      "permalink": "mr-kevin-pollack",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 130000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100112e61c000b5\u0026r=Rss\u0026s=DJFVLS",
   "source_description": "Diagnostic Hybrids To Sell For $130M In Grand Slam For Investor",
   "acquired_year": 2010,
   "acquired_month": 1,
   "acquired_day": 12,
   "acquiring_company":
    {"name": "Quidel",
     "permalink": "quidel",
     "image":
      {"available_sizes":
        [[[150,
           60],
          "assets/images/resized/0007/3167/73167v1-max-150x150.jpg"],
         [[202,
           81],
          "assets/images/resized/0007/3167/73167v1-max-250x250.jpg"],
         [[202,
           81],
          "assets/images/resized/0007/3167/73167v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1055 East State St",
    "address2": "Suite 100",
    "zip_code": "45701 ",
    "city": "Athens",
    "state_code": "OH",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/3171/73171v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/3171/73171v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/3171/73171v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}